The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, and GIPR variants that relate to GLP-1 and related signaling pathways
Just Results
Manish Sahni works with patients to minimize these effects by starting with the lowest possible dose and slowly increasing it over several months
You may benefit from GLP-1 therapy if: You are unable to lose weight despite healthy eating and exercise You struggle with sugar cravings or emotional snacking Youve experienced weight gain due to menopause or hormonal shifts You want to maintain weight loss in a sustainable way You are committed to long-term wellness, not just short-term results Flexible Programs with Medical Oversight A Safe and Effective Experience GLP-1 medications are prescription-only and require medical guidance
Novo Nordisk maintains that the benefit-risk profile of semaglutide, Ozempics active ingredient, is unchanged and emphasizes patient safety as a priority
Until now, there have been no robust, peer-reviewed, clinical trials that ensure the safety, efficacy, and long-term outcomes of microdosing GLP-1 medications